Fig. 5From: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro studyAn example of fluorescence images demonstrating the development of tail DNA after CAP treatment (a) intact DNA and (b) degraded DNA, (horizontal scale bar 100 μm)Back to article page